Neoplasms

53 researchers across 5 institutions

53 Researchers
5 Institutions
2 Grant PIs
4 High Impact

Research in neoplasms investigates the biological mechanisms, diagnosis, and treatment of cancerous growths. This area encompasses studies into tumor development, progression, and the cellular and molecular changes that drive malignancy. Researchers explore genetic and epigenetic alterations in cancer cells, investigate the tumor microenvironment, and develop novel diagnostic tools and therapeutic strategies. Studies range from fundamental laboratory investigations of cancer cell biology and metastasis to clinical research evaluating treatment efficacy and patient outcomes.

The study of neoplasms holds particular relevance for Arkansas, a state that faces significant cancer burdens and disparities. Research efforts contribute to understanding and addressing these public health challenges through improved diagnostics and treatment development. Furthermore, investigations into the environmental and occupational exposures relevant to Arkansas's industrial and agricultural sectors may shed light on cancer etiology within the state's population. This work supports the development of a skilled workforce and contributes to the state's health sector.

This research area draws on expertise from across multiple institutions in Arkansas, fostering collaboration among faculty and students. It is closely linked with investigations into cancer genomics, treatment pharmacology, molecular mechanisms, and health outcomes, reflecting a comprehensive approach to understanding and combating cancer.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Ruud P.M. Dings UAMS 40 5,225 Grant PI High Impact
Fred Prior UAMS 36 13,893 Grant PI High Impact
Harrison Brown UAMS 26 2,926 High Impact
Ronald L. Rardin University of Arkansas 23 2,678 High Impact
John D. Pemberton UAMS 19 1,744
Xiaomei Qu NCTR 13 826
Anupreet Kharbanda UAMS 12 454
Andrew Johns University of Central Arkansas 12 525
Roni M. Cox UAMS 12 553
Victor Ryu UAMS 10 406
Manish Gautam University of Arkansas 9 238
Richard E. Gardner UAMS 9 380
Nikhil Singh University of Arkansas – Fort Smith 7 375
Carmela Serpe UAMS 7 180
Naser Alqurini UAMS 6 173
Lakshmi Menon UAMS 5 145
Arup Ganguly UAMS 5 87
Nicholas A. Zoumberos UAMS 5 156
Bahaa Mustafa UAMS 4 100
Brannon Broadfoot UAMS 4 94

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
6,196 works in 2025
+6.0% CAGR 2018–2025
Leadership concentration
8.0% held by global top 5 institutions
Fragmented HHI 37
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,864
  2. 2 Mayo Clinic in Arizona 1,809
  3. 3 Mayo Clinic 1,407
  4. 4 Harvard University 1,192
  5. 5 Cleveland Clinic 1,119

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Neoplasms.

55%
Anusha Reddy Muddasani University of Arkansas
Xiaomei Qu NCTR
49%
Rui Zhang UAMS
42%
Anusha Reddy Muddasani University of Arkansas
K Ellis University of Arkansas – Fort Smith
42%
K Ellis University of Arkansas – Fort Smith
41%
Anusha Reddy Muddasani University of Arkansas
38%
K Ellis University of Arkansas – Fort Smith
37%
Mason G. Harper University of Arkansas
37%
Mason G. Harper University of Arkansas
36%

Researchers with Federal Grants

Browse All 53 Researchers in Directory